CVS " 健康 " 组织报告说,尽管机构股份减少,但收入和收入仍然强劲。 CVS Health reported strong earnings and revenue despite institutional shareholdings declining.

CVS Health看到几个机构在第一季度减少了它们的股份,同时报告的收入和收入高于预期。 CVS Health saw several institutions reduce their shareholdings in the first quarter while reporting better-than-expected earnings and revenue. 该公司的每股收入为2.25美元,超过估计的1.62美元,收入为945.9亿美元,超过了预测的930.7亿美元。 The company's earnings per share were $2.25, exceeding the $1.62 estimate, and revenue was $94.59 billion, surpassing the $93.07 billion forecast. CVS通过保健福利、保健服务、药房和消费者福利等部分运作。 CVS operates through segments like Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. 分析师有“机动购买”评级,目标价格为74.75美元。 Analysts have a "Moderate Buy" rating with a target price of $74.75.